The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial
Karkeet, Riham M, Zekri, Abdelrahman N, Sayed-Ahmed, Mohamed M, Sherif, Ghada M, Salem, Salem E, Abdelbary, Ahmed, Fouad, Mariam A, Saad, Sherif Y
Published in PloS one (08.12.2022)
Published in PloS one (08.12.2022)
Get full text
Journal Article
Fluoropyrimdine therapy induced alterations in interleukins expression in colorectal cancer patients
Fouad, Mariam A, Salem, Salem E, Osman, Afaf S, Badr, Doaa M, Hussein, Marwa M, Zekri, Abdelrahman N, Hafez, Hafez F, Kamel, Mahmoud M, Shouman, Samia A
Published in International journal of immunopathology and pharmacology (2021)
Published in International journal of immunopathology and pharmacology (2021)
Get full text
Journal Article
The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial
Riham M. Karkeet, Abdelrahman N. Zekri, Mohamed M. Sayed-Ahmed, Ghada M. Sherif, Salem E. Salem, Ahmed Abdelbary, Mariam A. Fouad, Sherif Y. Saad
Published in PloS one (08.12.2022)
Published in PloS one (08.12.2022)
Get full text
Journal Article
The Clinical Significance of Promoter Methylation of Fluoropyrimidine Metabolizing and Cyclooxygenase Genes in Colorectal Cancer
Fouad, Mariam Ahmed, Salem, Salem Eid, Hussien, Marwa M., Badr, Doaa Mohamed, Zekri, Abdelrahman N., Hafez, Hafez Farouk, Shouman, Samia A.
Published in Epigenetics insights (2021)
Published in Epigenetics insights (2021)
Get full text
Journal Article